Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 2/10

vs
industry
vs
history
Cash-to-Debt 0.09
CATS's Cash-to-Debt is ranked lower than
70% of the 211 Companies
in the Global Medical Care industry.

( Industry Median: 0.26 vs. CATS: 0.09 )
Ranked among companies with meaningful Cash-to-Debt only.
CATS' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.08  Med: 18.69 Max: No Debt
Current: 0.09
Equity-to-Asset -8.16
CATS's Equity-to-Asset is ranked lower than
100% of the 206 Companies
in the Global Medical Care industry.

( Industry Median: 0.45 vs. CATS: -8.16 )
Ranked among companies with meaningful Equity-to-Asset only.
CATS' s Equity-to-Asset Range Over the Past 10 Years
Min: -17.53  Med: -0.1 Max: 0.94
Current: -8.16
-17.53
0.94
Piotroski F-Score: 4
Altman Z-Score: -143.08
Beneish M-Score: -11.23
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
Operating Margin % -92.92
CATS's Operating Margin % is ranked lower than
97% of the 208 Companies
in the Global Medical Care industry.

( Industry Median: 6.49 vs. CATS: -92.92 )
Ranked among companies with meaningful Operating Margin % only.
CATS' s Operating Margin % Range Over the Past 10 Years
Min: -4518.73  Med: -747.18 Max: -92.92
Current: -92.92
-4518.73
-92.92
Net Margin % -253.51
CATS's Net Margin % is ranked lower than
99% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 4.00 vs. CATS: -253.51 )
Ranked among companies with meaningful Net Margin % only.
CATS' s Net Margin % Range Over the Past 10 Years
Min: -4463.39  Med: -725.31 Max: -103.32
Current: -253.51
-4463.39
-103.32
ROA % -641.81
CATS's ROA % is ranked lower than
100% of the 212 Companies
in the Global Medical Care industry.

( Industry Median: 3.51 vs. CATS: -641.81 )
Ranked among companies with meaningful ROA % only.
CATS' s ROA % Range Over the Past 10 Years
Min: -1099.34  Med: -144.38 Max: -35.93
Current: -641.81
-1099.34
-35.93
ROC (Joel Greenblatt) % -3045.78
CATS's ROC (Joel Greenblatt) % is ranked lower than
99% of the 210 Companies
in the Global Medical Care industry.

( Industry Median: 15.74 vs. CATS: -3045.78 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
CATS' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -9239.19  Med: -2145.37 Max: 72.47
Current: -3045.78
-9239.19
72.47
3-Year Revenue Growth Rate 35.00
CATS's 3-Year Revenue Growth Rate is ranked higher than
97% of the 178 Companies
in the Global Medical Care industry.

( Industry Median: 7.90 vs. CATS: 35.00 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
CATS' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -85.2  Med: -35.6 Max: 399.5
Current: 35
-85.2
399.5
3-Year EPS without NRI Growth Rate 18.20
CATS's 3-Year EPS without NRI Growth Rate is ranked higher than
68% of the 132 Companies
in the Global Medical Care industry.

( Industry Median: 8.30 vs. CATS: 18.20 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
CATS' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -87.1  Med: -32.1 Max: 149.1
Current: 18.2
-87.1
149.1
GuruFocus has detected 6 Warning Signs with Catasys Inc $CATS.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» CATS's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Insider Trades

Latest Guru Trades with CATS

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care    NAICS: 621498    SIC: 8093
Compare:OTCPK:MIHI, AMEX:HLTH, OTCPK:AMEH, NAS:JYNT, OTCPK:BRRZF, OTCPK:FCHS, NYSE:ADPT, OTCPK:CCEL, AMEX:AMS, OTCPK:BNKL, OTCPK:CVHIF, NYSE:AAC, OTCPK:BICX, AMEX:SSY, OTCPK:PFHO, OTCPK:WNDM, AMEX:HH, OTCPK:SPIN, OTCPK:CPAI, OTCPK:QNIID » details
Catasys Inc is a healthcare services company, provides health services designed to assist health plans & employees to manage & treat their high cost substance dependence members through a network of healthcare providers & its employees.

Catasys Inc was incorporated in the State of Delaware on September 29, 2003. It is a healthcare services company, provides specialized health services designed to assist health plans and other third-party payors to manage and treat their high cost substance dependence members through a network of healthcare providers and its employees. The OnTrak substance dependence program was designed to address substance dependence as a chronic disease. The program seeks improve member health through the delivery of integrated medical and psychosocial interventions in combination with long term care coaching. The Company's business segments: Healthcare Services. It operates in Kansas, Massachusetts, Louisiana, Oklahoma, Kentucky, West Virginia, and Wisconsin. The Company competes with Hummingbird, One Health Solutions, and Health Integrated. It also competes with other healthcare management service organizations, including managed behavioral health organizations. It owns trademarks for onTrak and eOnTrak.

Ratios

vs
industry
vs
history
PS Ratio 14.45
CATS's PS Ratio is ranked lower than
97% of the 232 Companies
in the Global Medical Care industry.

( Industry Median: 1.49 vs. CATS: 14.45 )
Ranked among companies with meaningful PS Ratio only.
CATS' s PS Ratio Range Over the Past 10 Years
Min: 0.44  Med: 13.39 Max: 190.85
Current: 14.45
0.44
190.85
EV-to-EBIT -8.85
CATS's EV-to-EBIT is ranked lower than
99.99% of the 192 Companies
in the Global Medical Care industry.

( Industry Median: 19.61 vs. CATS: -8.85 )
Ranked among companies with meaningful EV-to-EBIT only.
CATS' s EV-to-EBIT Range Over the Past 10 Years
Min: -207.9  Med: -2 Max: 41.6
Current: -8.85
-207.9
41.6
EV-to-EBITDA -8.95
CATS's EV-to-EBITDA is ranked lower than
99.99% of the 206 Companies
in the Global Medical Care industry.

( Industry Median: 14.29 vs. CATS: -8.95 )
Ranked among companies with meaningful EV-to-EBITDA only.
CATS' s EV-to-EBITDA Range Over the Past 10 Years
Min: -37.9  Med: -1.95 Max: 162.5
Current: -8.95
-37.9
162.5
Current Ratio 0.10
CATS's Current Ratio is ranked lower than
98% of the 199 Companies
in the Global Medical Care industry.

( Industry Median: 1.26 vs. CATS: 0.10 )
Ranked among companies with meaningful Current Ratio only.
CATS' s Current Ratio Range Over the Past 10 Years
Min: 0.1  Med: 0.96 Max: 15.93
Current: 0.1
0.1
15.93
Quick Ratio 0.10
CATS's Quick Ratio is ranked lower than
98% of the 199 Companies
in the Global Medical Care industry.

( Industry Median: 1.16 vs. CATS: 0.10 )
Ranked among companies with meaningful Quick Ratio only.
CATS' s Quick Ratio Range Over the Past 10 Years
Min: 0.1  Med: 0.96 Max: 15.93
Current: 0.1
0.1
15.93
Days Sales Outstanding 54.17
CATS's Days Sales Outstanding is ranked lower than
67% of the 174 Companies
in the Global Medical Care industry.

( Industry Median: 44.22 vs. CATS: 54.17 )
Ranked among companies with meaningful Days Sales Outstanding only.
CATS' s Days Sales Outstanding Range Over the Past 10 Years
Min: 14.36  Med: 56.83 Max: 83.75
Current: 54.17
14.36
83.75
Days Payable 68.00
CATS's Days Payable is ranked higher than
60% of the 140 Companies
in the Global Medical Care industry.

( Industry Median: 39.67 vs. CATS: 68.00 )
Ranked among companies with meaningful Days Payable only.
CATS' s Days Payable Range Over the Past 10 Years
Min: 39.06  Med: 683.08 Max: 2383.24
Current: 68
39.06
2383.24

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -43.20
CATS's 3-Year Average Share Buyback Ratio is ranked lower than
91% of the 126 Companies
in the Global Medical Care industry.

( Industry Median: -2.40 vs. CATS: -43.20 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
CATS' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -322  Med: -59.9 Max: -11.9
Current: -43.2
-322
-11.9

Valuation & Return

vs
industry
vs
history
Price-to-Median-PS-Value 1.08
CATS's Price-to-Median-PS-Value is ranked higher than
59% of the 196 Companies
in the Global Medical Care industry.

( Industry Median: 1.05 vs. CATS: 1.08 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
CATS' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.06  Med: 1.26 Max: 60.01
Current: 1.08
0.06
60.01
Earnings Yield (Greenblatt) % -11.30
CATS's Earnings Yield (Greenblatt) % is ranked lower than
94% of the 234 Companies
in the Global Medical Care industry.

( Industry Median: 3.94 vs. CATS: -11.30 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
CATS' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -11.3  Med: 3.1 Max: 4.5
Current: -11.3
-11.3
4.5

More Statistics

Revenue (TTM) (Mil) $7.08
EPS (TTM) $ -0.33
Beta1.32
Short Percentage of Float1.38%
52-Week Range $0.33 - 2.03
Shares Outstanding (Mil)55.29

Analyst Estimate

Dec17
Revenue (Mil $)
EPS ($) -0.02
EPS without NRI ($) -0.02
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)
» More Articles for CATS

Headlines

Articles On GuruFocus.com
No related article found.

More From Other Websites
CATASYS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Mar 21 2017
Catasys Expands Coverage of OnTrak-C Solution to Texas with Leading National Health Insurance... Mar 21 2017
CATASYS, INC. Files SEC form 8-K, Change in Directors or Principal Officers Mar 16 2017
Catasys, Inc. :CATS-US: Earnings Analysis: Q4, 2016 By the Numbers : March 16, 2017 Mar 16 2017
Catasys, Inc. :CATS-US: Earnings Analysis: 2016 By the Numbers : March 14, 2017 Mar 14 2017
CATASYS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Mar 08 2017
Catasys and Health Alliance Medical Plans Announce Expansion of OnTrak Mar 08 2017
CATASYS, INC. Financials Mar 07 2017
Catasys to Participate in the 29th Annual ROTH Conference on March 15, 2017 Mar 02 2017
CATASYS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Mar 01 2017
Catasys Reports Revenue Increase of 200% to $3.8 million for the Fourth Quarter of 2016 Mar 01 2017
CATASYS, INC. Files SEC form 10-K, Annual Report Feb 28 2017
Catasys Expands OnTrak-A Solution to Massachusetts with Leading National Health Insurance Provider Feb 16 2017
Catasys Expands OnTrak-A Solution to Texas with Leading National Health Insurance Provider Feb 07 2017
CATASYS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Feb 02 2017
Catasys Contracts with the Largest U.S. Health Insurance Company Feb 02 2017
CATASYS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct... Feb 01 2017
Catasys to Host Investor Call on February 2, 2017 Feb 01 2017
CATASYS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct... Dec 30 2016
CATASYS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of... Dec 23 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)